Myomo (MYO) Non-Current Debt (2017 - 2020)
Myomo posted quarterly Non-Current Debt of $77892.0 for Q2 2020, down 91.24% on a QoQ basis from $888961.0 in Q4 2019.
Myomo (MYO) has 3 years of Non-Current Debt data on file, last reported at $77892.0 in Q2 2020.
- For the quarter ending Q2 2020, Non-Current Debt changed N/A year-over-year to $77892.0; the trailing twelve-month figure through Jun 2020 stood at $77892.0 (changed N/A YoY), and the FY2019 full-year result was $888961.0, changed N/A from the prior year.
- Non-Current Debt for Q2 2020 stood at $77892.0, down from $888961.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $888961.0 in Q4 2019 and bottomed at $77892.0 in Q2 2020.
- The 3-year median for Non-Current Debt is $876458.0 (2017), against an average of $679942.2.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 77,892.00 |
| Jun 30, 2020 | 77,892.00 |
| Dec 31, 2019 | 888,961.00 |
| Dec 31, 2019 | 888,961.00 |
| Sep 30, 2017 | 876,458.00 |
| Sep 30, 2017 | 876,458.00 |
| Jun 30, 2017 | 876,458.00 |
| Jun 30, 2017 | 876,458.00 |